首页> 外文期刊>Urologia internationalis >Treatment and Outcomes of Urethral Recurrence of Urinary Bladder Cancer in Women after Radical Cystectomy and Orthotopic Neobladder: A Series of 12 Cases
【24h】

Treatment and Outcomes of Urethral Recurrence of Urinary Bladder Cancer in Women after Radical Cystectomy and Orthotopic Neobladder: A Series of 12 Cases

机译:膀胱切除术和原位新膀胱术后妇女膀胱膀胱尿道复发的治疗和结果:一系列12例

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: The incidence, treatment, and outcome of urethral recurrence (UR) after radical cystectomy (RC) for muscle-invasive bladder cancer with orthotopic neobladder in women have rarely been addressed in the literature. Patients and Methods: A total of 12 patients (median age at recurrence: 60 years) who experienced UR after RC with an orthotopic neobladder were selected for this study from a cohort of 456 women from participating institutions. The primary clinical and pathological characteristics at RC, including the manifestation of the UR and its treatment and outcome, were reviewed. Results: The primary bladder tumors in the 12 patients were urothelial carcinoma in 8 patients, squamous cell carcinoma and adenocarcinoma in 1 patient each, and mixed histology in 2 patients. Three patients (25%) had lymph node-positive disease at RC. The median time from RC to the detection of UR was 8 months (range 4-55). Eight recurrences manifested with clinical symptoms and 4 were detected during follow-up or during a diagnostic workup for clinical symptoms caused by distant metastases. Treatment modalities were surgery, chemotherapy, radiotherapy, and bacillus Calmette-Guerin urethral instillations. Nine patients died of cancer. The median survival after the diagnosis of UR was 6 months. Conclusions: UR after RC with an orthotopic neobladder in females is rare. Solitary, noninvasive recurrences have a favorable prognosis when detected early. Invasive recurrences are often associated with local and distant metastases and have a poor prognosis. (C) 2014 S. Karger AG, Basel
机译:简介:女性原位新膀胱肌浸润性膀胱癌根治性膀胱切除术(RC)后尿道复发(UR)的发生,治疗和结局很少在文献中提及。患者和方法:从参与机构的456名女性队列中选择了12例在原位新膀胱进行RC后发生UR的患者(复发年龄中位数:60岁)。回顾了RC的主要临床和病理特征,包括UR的表现及其治疗和预后。结果:12例患者的原发性膀胱肿瘤为尿路上皮癌8例,鳞状细胞癌和腺癌各1例,混合组织学检查2例。三名患者(25%)在RC时有淋巴结阳性。从RC到UR检测的中位时间为8个月(范围4-55)。在随访中或在诊断性检查中发现有8例复发表现为临床症状,其中4例是由远处转移引起的临床症状。治疗方式为手术,化学疗法,放射疗法和卡介苗-卡林芽孢杆菌尿道滴注。九名患者死于癌症。诊断为UR后的中位生存期为6个月。结论:RC后原位新膀胱的UR在女性中很少见。早期发现,孤立的,无创的复发预后良好。侵袭性复发通常与局部和远处转移有关,预后差。 (C)2014 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号